HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan Glass Selected Research

Radiotherapy

1/2011The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling.
8/2009Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan Glass Research Topics

Disease

16Neoplasms (Cancer)
01/2016 - 09/2004
9Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2021 - 01/2012
6Prostatic Neoplasms (Prostate Cancer)
03/2011 - 02/2005
4Squamous Cell Carcinoma of Head and Neck
12/2010 - 12/2003
3Infections
09/2022 - 08/2005
3Sepsis (Septicemia)
01/2019 - 08/2005
3Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2019 - 11/2013
3Frontotemporal Dementia (Semantic Dementia)
01/2019 - 11/2013
3Hypoxia (Hypoxemia)
04/2012 - 03/2011
3Margins of Excision
12/2010 - 09/2004
2Kidney Calculi (Kidney Stone)
09/2022 - 05/2013
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 11/2013
2Multiple Myeloma
01/2016 - 04/2005
2Residual Neoplasm
12/2010 - 03/2007
2Calculi (Calculus)
01/2008 - 08/2005
1Cognitive Dysfunction
01/2022
1Disease Progression
04/2021
1Tauopathies
01/2021
1Embolism (Embolus)
01/2020
1Leukocytosis (Pleocytosis)
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1Nonaka type Distal myopathy
01/2019
1Pathologic Constriction (Stenosis)
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Muscular Diseases (Myopathy)
01/2019
1Skin Diseases (Skin Disease)
01/2019
1Weight Loss (Weight Reduction)
10/2018
1Inflammation (Inflammations)
01/2017
1Urinary Calculi (Urinary Calculus)
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
06/2014
1Congenital Abnormalities (Deformity)
01/2014
1Sickle Cell Anemia (Hemoglobin S Disease)
11/2012
1Thalassemia
11/2012
1Urinary Retention
08/2012
1Hepatocellular Carcinoma (Hepatoma)
04/2012
1Anemia
07/2011
1Ovarian Neoplasms (Ovarian Cancer)
11/2010

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2003
4TOR Serine-Threonine KinasesIBA
12/2010 - 09/2004
4CCAAT-Enhancer-Binding Protein-alphaIBA
06/2009 - 02/2005
3RNA (Ribonucleic Acid)IBA
01/2019 - 02/2005
3DNA-Binding Proteins (DNA Binding Protein)IBA
01/2019 - 11/2013
3Biomarkers (Surrogate Marker)IBA
11/2013 - 12/2010
3IronIBA
04/2012 - 03/2011
3temsirolimusFDA Link
12/2010 - 03/2007
3transporter associated with antigen processing (TAP)IBA
11/2009 - 08/2008
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2021
2Biological ProductsIBA
01/2018 - 11/2010
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
10/2014 - 01/2013
2MTOR InhibitorsIBA
12/2010 - 03/2007
2Cisplatin (Platino)FDA LinkGeneric
07/2010 - 08/2009
2Radiation-Sensitizing AgentsIBA
08/2009 - 12/2003
2Eukaryotic Initiation Factor-4EIBA
03/2007 - 09/2004
1tofersenIBA
01/2020
1HLA-DQA2 antigenIBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Racemases and Epimerases (Epimerases and Racemases)IBA
01/2019
1VaccinesIBA
01/2019
1Uridine Diphosphate (UDP)IBA
01/2019
1N-acylmannosamine kinaseIBA
01/2019
1Butyrates (Butyrate)IBA
10/2018
1ProgranulinsIBA
01/2018
1ProteomeIBA
01/2017
1Cephalosporins (Cephalosporin Antibiotics)IBA
10/2014
1Interleukin-23 (Interleukin 23)IBA
11/2013
1Threonine (L-Threonine)FDA Link
11/2013
1SodiumIBA
11/2012
12,2-dimethylbutyric acidIBA
11/2012
1GlobinsIBA
11/2012
1ferric ammonium citrateFDA Link
04/2012
1Oxygen (Dioxygen)IBA
04/2012
1Antineoplastic Agents (Antineoplastics)IBA
04/2012
1Therapeutic UsesIBA
04/2012
1Messenger RNA (mRNA)IBA
04/2012
1HepcidinsIBA
07/2011
1pimonidazoleIBA
07/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2011
1Transferrin Receptors (Transferrin Receptor)IBA
03/2011
1Ferritins (Ferritin)IBA
03/2011
1Chelating AgentsIBA
03/2011
1Core Binding Factors (Core-Binding Factor)IBA
11/2010
1Small Interfering RNA (siRNA)IBA
11/2010

Therapy/Procedure

9Therapeutics
09/2022 - 06/2003
4Stents
02/2020 - 08/2005
4Stem Cell Transplantation
01/2016 - 04/2005
2Transplantation
04/2021 - 05/2013
2Catheters
08/2012 - 06/2003
2Radiotherapy
01/2011 - 08/2009
2Molecular Targeted Therapy
08/2009 - 03/2007
1Minimally Invasive Surgical Procedures
09/2022
1Spinal Injections
04/2021
1Laparotomy
01/2019
1Nephrotomy
01/2019
1Autologous Transplantation
01/2016
1Length of Stay
01/2016
1Enteral Nutrition (Feeding, Tube)
06/2014
1Laminoplasty
01/2014
1Blood Transfusion (Blood Transfusions)
11/2013
1Biological Therapy
08/2012
1Drug Therapy (Chemotherapy)
01/2011